Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference44 articles.
1. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020 [Internet]. Washington DC: U.S. Department of Health & Human Services; [Updated 2020 February 11; Cited 2021 December 12]. https://www.cdc.gov/diabetes/library/features/diabetes-stat-report.html.
2. American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diabetes Care. 2018;41(5):917–27.
3. Trikkalinou A, Papazafiropoulou AK, Melidonis A. Type 2 diabetes and quality of life. World J Diabetes. 2017;8(4):120–9.
4. Alzaid A, Ladrón de Guevara P, Beillat M, Lehner MV, Atanasov P. Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses. Expert Rev Pharmacoecon Outcomes Res. 2021;21(4):785–798.
5. Kirkman MS, McCarren M, Shah J, Duckworth W, Abraira C. VADT Study Group. The association between metabolic control and prevalent macrovascular disease in type 2 diabetes: the VA Cooperative Study in diabetes. J Diabetes Complic. 2006;20(2):75–80.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献